Search

everythinglearnresearchcommunity

for

Search:↓

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Methotrexate, resveratrol, and curcumin may help treat alopecia areata by targeting immune cells.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Using a specific binding agent and low doses of FK506 can stimulate stem cells, speeding up skin healing by 25% and improving skin quality in rats and mice.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The combination therapy was effective and well-tolerated, especially in young patients.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Entospletinib effectively prevents eye and skin GVHD in mice.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Blocking a specific immune cell signal can trigger hair growth.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

IL-18 signaling helps mature Tregs move into the thymus.

IL-18 signaling helps mature Tregs move into the thymus.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.